Citations 1
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia
Rowe, Jacob M. , Buck, Georgina , Foroni, Letizia, Gerrard, Gareth , Litzow, Mark R. , Lazarus, Hillard, Luger, Selina M. , Marks, David I. , McMillan, Andrew , Moorman, Anthony V. , Patel, Bella, Paietta, Elisabeth , Tallman, Martin S. , Goldstone, Anthony H., Fielding, Adele K.
Blood | November 26, 2013 | Volume: 123 | Issue: 6 | Pages: 843-850
Key Points Imatinib improves outcomes for adults with Ph+ ALL at least in part by facilitating allogeneic stem cell transplant. Allogeneic hematopoietic stem cell transplant is not dispensible in Ph+ ALL in the imatinib era.